go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Michigan rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $977,237 · 10th–90th $489,779$1,621,8100%20%10th90th$977,237Professionalmedian $489,779 · 10th–90th $489,779$537,0320%50%90th$489,779$1.0$10.0$100.0$1.0K$10.0K$100.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$501,187.23
Median
$977,237.22
Typical High
$1,412,537.54
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$537,031.80
BCBS
Setting
Facility
Modifier
Global
Typical Low
$7,943.28
Median
$1,023,292.99
Typical High
$2,089,296.13
BCBS
Setting
Professional
Modifier
Global
Typical Low
$478,630.09
Median
$501,187.23
Typical High
$524,807.46
Cigna
Setting
Professional
Modifier
Global
Typical Low
$467,735.14
Median
$512,861.38
Typical High
$794,328.23
Health Alliance Plan
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$1,230,268.77
Typical High
$1,584,893.19
Health Alliance Plan
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$645,654.23
Priority Health
Setting
Professional
Modifier
Global
Typical Low
$467,735.14
Median
$489,778.82
Typical High
$794,328.23
United
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$467,735.14
Typical High
$776,247.12